Capital Advisors Ltd’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
Capital Advisors Ltd's AVXL Position: Q3 2026 in Review
Capital Advisors Ltd reduced its Anavex Life Sciences (AVXL) stake by 83% in Q3 2026, selling an estimated $1.12K and leaving 80 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1477.
Capital Advisors Ltd first reported a position in AVXL in Q2 2026 and has held it in 2 quarters since. The position peaked at $1K in Q2 2026. 167 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.
- Capital Advisors Ltd held 80 shares of Anavex Life Sciences worth $0 as of Q3 2026.
- Capital Advisors Ltd sold 404 Anavex Life Sciences shares in Q3 2026, an estimated $1.12K.
- Anavex Life Sciences made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q3 2026, its #1477 holding.
- Capital Advisors Ltd first reported a position in Anavex Life Sciences in Q2 2026 and has held it in 2 quarters since.
- Capital Advisors Ltd's Anavex Life Sciences position peaked at $1K in Q2 2026.
- 167 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.
Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.